Patent ID: 8709802

Claim:
A composition of matter comprising an isolated population of at least 5 million lineage specific precursor/progenitor (LSP) cells comprising a first, a second and a third subpopulation of cells, wherein the first subpopulation of cells comprises at least 5.9% of the total LSP cell population and expresses CD304, wherein the second subpopulation of cells comprises at least 2.0% of the total LSP cell population and expresses CD34 and CD184, and wherein the third subpopulation of cells comprises the remainder of the LSP cell population, wherein the third subpopulation of cells comprises a CD309 and CD202b expressing population, and wherein the CD309 and CD202b expressing population comprises at least 0.2% of the total LSP cell population, wherein the third subpopulation of cells further comprises a CD31 and VEGFR1 expressing population, and wherein the CD31 and VEGFR1 expressing population comprises at least 2.3% of the total LSP cell population, and wherein the third subpopulation of cells further comprises a population of cells that uptake Ac-LDL and express Ulex lectin, and wherein the population of cells that uptake Ac-LDL and express Ulex lectin comprises between 7% and 41.5% of the total LSP cell population.